What everyone is pushing with that is for clinical trials. The equivalent of an accelerated IND by the FDA. For emergency approval it would be an EAMS and the MHRA hasn't provided a timeline for that. I would expect it to be highly accelerated for COVID-19 but 72 hours is probably an unrealistic expectation.